Tag: illinois asbestos lawyer

A clinical study of malignant pleural mesothelioma patients treated with investigational cancer vaccine CRS-207 at University of Chicago Medical Center, UCSF’s cancer center, the Moffitt Cancer Center in Tampa, the Abramson Cancer Center in Philadelphia and the National Cancer Institutein Bethesda, Maryland has shown promising results in shrinking tumors. CRS-207 caused tumor shrinkage in 85% of patients and the overall disease control rate was 94%. Patients were given two bacterial of Listeria monocytogenes infusions two weeks […]Continue reading

0